
1. science. 2011 aug 5;333(6043):705-6. doi: 10.1126/science.1210875.

microbiology. exploiting malaria drug resistance advantage.

cammack n(1).

author information: 
(1)glaxosmithkline, madrid, 28760 spain. nicholas.c.cammack@gsk.com

comment on
    science. 2011 aug 5;333(6043):724-9.

doi: 10.1126/science.1210875 
pmid: 21817037  [indexed medline]

